Form 8-K - Current report:
SEC Accession No. 0001193125-25-072356
Filing Date
2025-04-03
Accepted
2025-04-03 16:05:46
Documents
14
Period of Report
2025-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d945856d8k.htm   iXBRL 8-K 28810
  Complete submission text file 0001193125-25-072356.txt   194596

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA autl-20250228.xsd EX-101.SCH 3534
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE autl-20250228_def.xml EX-101.DEF 14524
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE autl-20250228_lab.xml EX-101.LAB 24278
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE autl-20250228_pre.xml EX-101.PRE 15432
16 EXTRACTED XBRL INSTANCE DOCUMENT d945856d8k_htm.xml XML 5892
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 25809374
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)